Financials data is unavailable for this security.
View more
Year on year Xinjiang Bai Hua Cun Pharma Tech Co Ltd grew revenues 5.54% from 349.88m to 369.28m while net income improved from a loss of 34.75m to a gain of 12.97m.
Gross margin | 47.94% |
---|---|
Net profit margin | 5.68% |
Operating margin | 6.88% |
Return on assets | 2.12% |
---|---|
Return on equity | 3.19% |
Return on investment | 2.99% |
More ▼
Cash flow in CNYView more
In 2023, Xinjiang Bai Hua Cun Pharma Tech Co Ltd increased its cash reserves by 48.88%, or 66.34m. The company earned 62.08m from its operations for a Cash Flow Margin of 16.81%. In addition the company generated 19.91m cash from financing while 15.65m was spent on investing.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.92 |
---|---|
Tangible book value per share | 1.82 |
More ▼
Balance sheet in CNYView more
Current ratio | 1.81 |
---|---|
Quick ratio | 1.43 |
Total debt/total equity | 0.0719 |
---|---|
Total debt/total capital | 0.067 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items increased 136.97%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 169.62 |